ARKG - ARK Genomic Revolution ETF
| Previous Close | 34.10 |
| Open | 34.30 |
| Bid | 32.10 x 800 |
| Ask | 34.59 x 1000 |
| Day's Range | 34.08 - 34.62 |
| 52 Week Range | 21.98 - 35.54 |
| Volume | 67,186 |
| Avg. Volume | 102,011 |
| Net Assets | 478.28M |
| NAV | 34.55 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Daily Total Return | 43.72% |
| Beta (3Y Monthly) | 1.97 |
| Expense Ratio (net) | 0.75% |
| Inception Date | 2014-10-30 |
- Zacks
A Guide to Biotech ETF Investing
Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.
- Zacks
Biotech Tops in November: Best ETFs & Stocks
The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.
- Zacks
The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG
The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG
- Zacks
Why Gold is Headed to Zero -- And What You Should Buy Instead
Why Gold is Headed to Zero -- And What You Should Buy Instead
- Zacks
Genomics ETFs Surge on CRISPR's Gene Editing Progress
The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.
- ETF Database
ARK Invest ETFs Focus on Disruptive Companies
For anyone not familiar with ARK Invest, they have a suite of ETF strategies dedicated to helping investors hone in on disruptive innovations and technologies with the potential to affect the global economy.
- ETF Trends
ARK Invest ETFs Track Disruptive Companies Changing the World
For anyone not familiar with ARK Invest, they have a suite of ETF strategies dedicated to helping investors hone in on disruptive innovations and technologies with the potential to affect the global economy. ...
- ETF Trends
An Active ETF Approach to Target Innovations in Next Generation Sequencing
There are new developments in DNA sequencing that are making a huge impact on healthcare and the direction of growth in the industry. To take advantage of this opportunity, investors can look to a targeted ETF strategy to gain exposure to this next generation of DNA sequencing. In the recent webcast, Next Generation DNA Sequencing: An Investor Field Guide, Simon Barnett, Analyst, Genomic Revolution, ARK Invest; and Tom Staudt, Chief Operating Officer, ARK Invest, sought to to size the potential investment opportunity in innovative technologies, notably those in the healthcare industry and DNA sequencing.
- Zacks
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks
Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.
- ETF Trends
Next Generation DNA Sequencing: An Investor Field Guide
Next generation DNA sequencing could set the stage for a new era in medicine given its accuracy, cost-effectiveness, and soon—affordability. In the upcoming webcast, Next Generation DNA Sequencing: An ...
- Zacks
S&P 500 at Record High: 6 ETF Winners of Last Week
The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.
- MarketWatch
Is it time for ETFs to get active?
As ETFs mature and the appeal of their structure becomes more accepted, fund managers will increasingly opt to use an ETF framework, rather than a mutual fund, as the backbone for their investing strategies.
- Zacks
Navigating The Healthcare Industry: Science Fiction Turns to Reality
Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!
- Zacks
Tap Revenue Growth With These ETFs & Dump Earnings Recession
These sector ETFs could be played to highlight revenue growth in the third quarter.
- ETF Trends
How ETF Investors Could Enhance a Portfolio with Disruptive Innovative Companies
ETF investors who want to diversify into new areas of potential growth should identify areas of innovation and look to technologies that are disrupting the markets. On the recent webcast, Focusing on Disruptive ...
- ETF Trends
Focusing on Disruptive Innovation for Changing Markets
While uncertainties may affect the various market segments in the short run, the long-term trends reveal a global economy that is quickly advancing technologies that can disrupt markets and provide further ...
- ETF Database
World’s Largest Genetics Project Has “ARKG” ETF on Watch
UK Biobank, an international health resource and charity, is leading the charge in what is the world’s largest genetics project, which should put the ARK Genomic Revolution Multi-Sector ETF (ARKG ) on watch for investors.
- ETF Trends
World’s Largest Genetics Project Puts “ARKG” ETF on Watch
UK Biobank, an international health resource and charity, is leading the charge in what is the world’s largest genetics project, which should put the ARK Genomic Revolution Multi-Sector ETF (ARKG) on watch for investors. Per a Technology Networks report, “The biobank recruited 500,000 volunteers aged between 40–69 years from across the country and collected a variety of biological measures and data from them, including blood, urine and saliva samples. The primary goal of the project is to collect data in order to best determine the pathophysiology and heterogeneity of human diseases.
- Zacks
ETFs Poised to Benefit from Gene Editing Revolution
Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.
- Zacks
ETFs to Gain From the Booming Genomics Market
Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.
- Zacks
Top-Performing Biotech ETFs YTD
Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.
- Zacks
5 U.S. ETFs Seeing Fireworks Ahead of July Fourth
These ETFs focus exclusively on U.S. equities and deserve the attention of investors seeking a domestic tilt to their portfolio ahead of the Jul 4 holiday.
- Zacks
5 Sector ETFs That Beat the Market in the First Half
With just a trading session left to end the first half, the Dow Jones is up about 13.7% while the S&P 500 and Nasdaq have gained 16.7% and 20.1%, respectively.
- Zacks
Why These Innovative Biotech ETFs Soaring
Strong M&A activity has sent shares of many small, innovative biotech companies surging
- ETF Database
4 ETFs to Help Investors Access Innovative Disruptors
New disruptive technologies are changing the way we interact with the world, providing growth opportunities for exchange traded fund investors whom are looking to diversify into these quickly developing segments.
